Seamless Therapeutics, a German biotechnology firm, has successfully concluded a USD12.5 million Seed Financing, a university carve-out including equity financing, in-licensing of an innovative patent portfolio from Technische Universität Dresden and hiring of key
Tags :Tiziana Hongler
Baker McKenzie has advised Tandem Diabetes Care, a global insulin delivery and diabetes technology company, on its purchase of AMF Medical, a privately held Swiss insulin patch pump developer. AMF Medical’s technology aligns well
Baker McKenzie has advised Mövenpick Group in selling the multi-brand international catering company Marché International to Lagardère Travel Retail, the travel retail division of the French Lagardère Group. The sale completes the
Baker McKenzie Switzerland has advised publicly listed Datwyler, a specialist for system-critical elastomer components, on its acquisition of Swiss startup company CTsystems. With this acquisition, Datwyler is able to strengthen its position for the future
Baker McKenzie Switzerland advised the shareholders of Sauter, Bachmann (“Sauter Bachmann”) with regard to the succession solution for shareholder Martin Sauter, who will retire on 1 January 2023. SIC Group is taking over Martin Sauter’s share
Baker McKenzie advised Amsterdam-based Keesing Media Group (Keesing) on the acquisition of the Swiss Küng Group. The deal will enable Keesing to to strengthen its European market presence and develop a stronger foothold in